House Commerce oversight of FDA agenda will be influenced by WLF president and new staffer Slobodin.
Executive Summary
HOUSE COMMERCE OVERSIGHT OF FDA AGENDA WILL BE SHAPED BY WLF President and Legal Studies Division General Counsel Alan Slobodin, who is set to become counsel to the House Commerce Committee on Jan. 24. Although an employee of the full committee, Slobodin is likely to play a role in the development of hearings in the Oversight Subcommittee.
You may also be interested in...
Pediatric Prozac Phase IV Commitments Will Test Exclusivity Incentive
Lilly's Phase IV commitments for additional research on pediatric use of Prozac will serve as a high-profile test of FDA's pediatric exclusivity incentive
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011